Clinical Trials Directory

Trials / Conditions / Uterine Corpus Leiomyosarcoma

Uterine Corpus Leiomyosarcoma

10 registered clinical trials studyying Uterine Corpus Leiomyosarcoma.

StatusTrialSponsorPhase
Active Not RecruitingA Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advance
NCT03880019
National Cancer Institute (NCI)Phase 2
CompletedNivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma
NCT02428192
National Cancer Institute (NCI)Phase 2
TerminatedGemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has
NCT01958580
Albert Einstein College of MedicineN/A
CompletedAlisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
NCT01637961
National Cancer Institute (NCI)Phase 2
TerminatedGemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patie
NCT01533207
Gynecologic Oncology GroupPhase 3
CompletedIxabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated
NCT01220609
National Cancer Institute (NCI)Phase 2
TerminatedGemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recu
NCT01012297
National Cancer Institute (NCI)Phase 3
CompletedCombination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Can
NCT00031629
Gynecologic Oncology GroupPhase 2
CompletedThalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus
NCT00025220
National Cancer Institute (NCI)Phase 2
CompletedCollecting Tumor Samples From Patients With Gynecological Tumors
NCT00897442
Gynecologic Oncology Group—